{"id":46,"date":"2023-12-11T09:44:40","date_gmt":"2023-12-11T09:44:40","guid":{"rendered":"https:\/\/eua25.org\/?page_id=46"},"modified":"2023-12-11T09:44:40","modified_gmt":"2023-12-11T09:44:40","slug":"konu-basliklari","status":"publish","type":"page","link":"https:\/\/eua25.org\/en\/konu-basliklari\/","title":{"rendered":"Topics"},"content":{"rendered":"<ul class=\"wp-block-list\">\n<li>MRI-US f\u00fczyon biyopsisine dayal\u0131 3D-Kanser haritas\u0131n\u0131n klinik uygulamas\u0131<\/li>\n\n\n\n<li>Transperineal prostat biyopsisi: Ne zaman ve kime<\/li>\n\n\n\n<li>Prostat kanseri: Prognostik ve terap\u00f6tik doku belirte\u00e7leri<\/li>\n\n\n\n<li>PSA ile tarama\u2019da ne durumday\u0131z?<\/li>\n\n\n\n<li>Aktif izlem ve fokal ablasyon i\u00e7in hasta se\u00e7iminde biyobelirte\u00e7lerin kullan\u0131m\u0131<\/li>\n\n\n\n<li>Prostat kanseri:<\/li>\n\n\n\n<li>Metastatik prostat kanserinde germline mutasyonlar\u0131: Tedavi se\u00e7iminde etkisi<\/li>\n\n\n\n<li>Prostat Kanserinde \u0130ntegratif Onkoloji<\/li>\n\n\n\n<li>Prostat kanseri te\u015fhisi sonras\u0131nda beslenme<\/li>\n\n\n\n<li>Lokalize prostat kanserinin tedavisinde cerrahi d\u0131\u015f\u0131 tedaviye ili\u015fkin yeni yakla\u015f\u0131mlar:HIFU, CRYO<\/li>\n\n\n\n<li>Tedavi algoritmas\u0131nda Lu-177: Ne anlam ifade ediyor?<\/li>\n\n\n\n<li>Metastatik prostat kanserinde Alfaridin<\/li>\n\n\n\n<li>Metastatik ve oligometastatik prostat kanserinde primer radyoterapi<\/li>\n\n\n\n<li>Prostat kanserinde tedavi se\u00e7enekleri hormon duyarl\u0131 d\u00f6neme mi ta\u015f\u0131n\u0131yor?<\/li>\n\n\n\n<li>Non-metastatik kastrasyon diren\u00e7li prostat kanserinde tedavi yakla\u015f\u0131mlar\u0131<\/li>\n\n\n\n<li>Vaka tart\u0131\u015fmalar\u0131-Prostat<\/li>\n\n\n\n<li>\u00dcrotelyal karsinom tan\u0131s\u0131nda idrar sitolojisindeki yenilikler<\/li>\n\n\n\n<li>VI-RADS (Vezikal g\u00f6r\u00fcnt\u00fcleme \u2013 Raporlama ve veri sistemi)<\/li>\n\n\n\n<li>K\u0130OMK i\u00e7in optimal tedaviler ve yeni yakla\u015f\u0131mlar<\/li>\n\n\n\n<li>Robotik sistektomi ve \u00fcriner diversiyon<\/li>\n\n\n\n<li>Cerrahinin gelece\u011fi 2040<\/li>\n\n\n\n<li>Mesane kanseri ve immunoterapi<\/li>\n\n\n\n<li>Mesane kanseri tedavisinde anti FGFR ajanlar<\/li>\n\n\n\n<li>Sistektomiye uygun olmayan hastalar i\u00e7in se\u00e7enekler<\/li>\n\n\n\n<li>Panel tart\u0131\u015fma: Y\u00fcksek riskli K\u0130OMK\u2019nin y\u00f6netiminin optimizasyonu \u2013 Vaka bazl\u0131 tart\u0131\u015fma<\/li>\n\n\n\n<li>Sistektomi veya neoadjuvan kemoterapi \u00f6ncesinde maksimal TURMT sonu\u00e7lar\u0131 iyile\u015ftirir mi?<\/li>\n\n\n\n<li>Art\u0131lar\/Eksiler: Lenf nodu metastaz\u0131 varl\u0131\u011f\u0131nda \u00fcrotelyal kanserde cerrahinin rol\u00fc var m\u0131?<\/li>\n\n\n\n<li>Vaka tart\u0131\u015fmalar\u0131 -Mesane (30\u2032)<\/li>\n\n\n\n<li>\u00dcst sistem \u00fcrotelyal karsinomun y\u00f6netiminde yeni bak\u0131\u015f a\u00e7\u0131lar\u0131<\/li>\n\n\n\n<li>\u00dcst \u00fcriner sistem \u00fcrotelyal kanserlerinde neoadjuvan vs. adjuvan kemoterapi<\/li>\n\n\n\n<li>Nadir kal\u0131t\u0131msal renal h\u00fccre karsinomlar\u0131: Radyologlar\u0131n bilmesi gerekenler<\/li>\n\n\n\n<li>Renal h\u00fccre karsinomlar\u0131 i\u00e7in yeni hedefler ve yeni belirte\u00e7ler<\/li>\n\n\n\n<li>Renal kitlelerin alt tip tan\u0131mlanmas\u0131nda radyolojik de\u011ferlendirme<\/li>\n\n\n\n<li>Renal h\u00fccre karsinomu i\u00e7in izlem: Daha iyi bir yol var m\u0131?<\/li>\n\n\n\n<li>\u0130nteraktif panel tart\u0131\u015fmas\u0131: Lokal olarak \u0130lerlemi\u015f ve metastatik RHK i\u00e7in cerrahi ve sistemik tedavinin entegrasyonu<\/li>\n\n\n\n<li>Adjuvan RHK \u00e7al\u0131\u015fmalar\u0131n\u0131 nas\u0131l yorumlayal\u0131m?<\/li>\n\n\n\n<li>Vaka tart\u0131\u015fmalar\u0131-B\u00f6brek<\/li>\n\n\n\n<li>Test\u0130k\u00fcler germ h\u00fccreli t\u00fcm\u00f6rler i\u00e7in yeni bir t\u00fcm\u00f6r belirteci olarak serum MikroRNA<\/li>\n\n\n\n<li>Evre I-IIa testis t\u00fcm\u00f6rlerinde primer RPLND<\/li>\n\n\n\n<li>Art\u0131lar\/Eksiler: Minimal invazif RPLND<\/li>\n\n\n\n<li>\u0130lerlemi\u015f GHT\u2019de cerrahi kurtarma\/Ge\u00e7 n\u00fcks cerrahinin rol\u00fc hakk\u0131nda g\u00fcncelleme<\/li>\n\n\n\n<li>Testis kanseri sistemik tedavisinde yenilikler<\/li>\n\n\n\n<li>Klinisyenler i\u00e7in molek\u00fcler biyoloji okuryazarl\u0131\u011f\u0131<\/li>\n\n\n\n<li>\u0130mm\u00fcnoonkolojide temel kavramlar<\/li>\n\n\n\n<li>Pelvik lenfadenektominin mevcut durumu: Yap\u0131lmal\u0131 m\u0131 yap\u0131lmamal\u0131 m\u0131?<\/li>\n\n\n\n<li>Kastrasyona diren\u00e7li prostat kanseri h\u00fccrelerinde OCT1\u2019in epigenetik reg\u00fclasyonu<\/li>\n\n\n\n<li>\u00dcrobiom ve mesane kanseri: yeni bir ara\u015ft\u0131rma alan\u0131<\/li>\n\n\n\n<li>Prostata Perineal Yakla\u015f\u0131m \u2013 Ni\u00e7in? Ne zaman?<\/li>\n\n\n\n<li>G\u00fcncel bilateral adrenektomi, ICG Kullan\u0131m\u0131<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-46","page","type-page","status-publish","hentry"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/pages\/46","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/comments?post=46"}],"version-history":[{"count":0,"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/pages\/46\/revisions"}],"wp:attachment":[{"href":"https:\/\/eua25.org\/en\/wp-json\/wp\/v2\/media?parent=46"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}